Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Treatment of bone metastases and bone pain with bisphosphonates
Allan Lipton
Department of Medicine
Division of Hematology and Oncology
Penn State Cancer Institute
Research output
:
Contribution to journal
›
Review article
›
peer-review
49
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of bone metastases and bone pain with bisphosphonates'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Solid Tumors
100%
Bisphosphonates
100%
Bone Pain
100%
Zoledronic Acid
75%
Skeletal-related Events
75%
Skeletal Complications
75%
Placebo
75%
Bone Metastasis
50%
Skeletal Morbidity
50%
Metastatic Breast Cancer
50%
Patient Well-being
50%
Functional Independence
50%
Pathologic Fracture
50%
Lung Cancer
25%
Orthopedic Surgery
25%
High Risk
25%
Clinical Benefit
25%
Lung-other
25%
Significant Benefit
25%
Metastasizing
25%
Treatment Duration
25%
Clodronate
25%
Spinal Cord Compression
25%
Palliative Radiotherapy
25%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
25%
Ibandronate
25%
Malignant Bone Disease
25%
Treatment Timing
25%
Dose Timing
25%
Skeletal Health
25%
Subsequent Events
25%
Pain Reduction
25%
Medicine and Dentistry
Solid Malignant Neoplasm
100%
Bone Metastasis
100%
Bone Pain
100%
Bisphosphonate
100%
Zoledronic Acid
75%
Placebo
75%
Quality of Life
50%
Metastatic Breast Cancer
50%
Pathologic Fracture
50%
Prostate Cancer
25%
Lung Cancer
25%
Treatment Duration
25%
Pamidronic Acid
25%
Clodronic Acid
25%
Spinal Cord Compression
25%
Ibandronic Acid
25%
Diseases
25%
Orthopedic Surgery
25%
Palliative Radiation Therapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Bone Metastasis
100%
Solid Malignant Neoplasm
100%
Bisphosphonic Acid Derivative
100%
Bone Pain
100%
Zoledronic Acid
75%
Placebo
75%
Metastatic Breast Cancer
50%
Pathologic Fracture
50%
Pamidronic Acid
25%
Prostate Cancer
25%
Lung Cancer
25%
Clodronic Acid
25%
Spinal Cord Compression
25%
Diseases
25%
Bone Disease
25%